[Comparison of 16S rRNA gene hypervariable regions V3-V4 and V4 sequencing results of gut microbiota in obese children with non-alcoholic fatty liver disease]. [PDF]
Huang Z +9 more
europepmc +1 more source
[Comparative Analysis of Oral and Gut Microbiota Composition in Children Aged 3-5 Years With Different Body Mass Indexes in Urumqi]. [PDF]
Ma T, Wu Z, Lian B, Zhao J.
europepmc +1 more source
[Changes of intestinal microflora in patients with colorectal benign and malignant tumors in high altitude area and comparison with the normal population in low altitude area]. [PDF]
Han D, Ciren Y, Li Q, Li J.
europepmc +1 more source
[Characteristics of intestinal microbiota in the acute phase of Kawasaki disease in infants and children]. [PDF]
Wang HM +7 more
europepmc +1 more source
[<i>Poria cocos</i> polysaccharide alleviates cyclophosphamide-induced intestinal barrier dysfunction and inflammation in mice by modulating gut flora]. [PDF]
Zhang Y +10 more
europepmc +1 more source
[Research progress on the effects of maternal gut microbiota in gestational obesity on offspring and potential mechanisms]. [PDF]
Jia Q, Yu YH, Wu YJ, Han TY.
europepmc +1 more source
[Pentosan polysulfate alleviates cyclophosphamide-induced interstitial cystitis/bladder pain syndrome in mice by modulating gut microbiota and bile acid metabolism]. [PDF]
Zhu Y, Zhu Z, Wu P.
europepmc +1 more source
[Toxicity of lunar dust simulant exposure via the digestive system: Microbiota dysbiosis and multi-organ injury]. [PDF]
Chen Y +8 more
europepmc +1 more source
[Specific changes in gut microbiota and short-chain fatty acid levels in infants with cow's milk protein allergy]. [PDF]
Yu ZD +6 more
europepmc +1 more source
[The microbiota-gut-brain axis in childhood attention-deficit/hyperactivity disorder: mechanisms and therapeutic advances]. [PDF]
Yuan YL, Lan YM, Guo LM.
europepmc +1 more source

